World Health Organization (2016). Developing pharmacy practice—A focus on patient care. Department of Medicines Policy and Standards; International Pharmaceutical Federation. Geneva, Switzerland: WHO.

Ni XF, Yang CS, Bai YM, Hu ZX, Zhang LL. Drug-related problems of patients in Primary Health Care Institutions: A Systematic Review. Front Pharmacol. 2021;12:698907.

Paisansirikul A, Ketprayoon A, Ittiwattanakul W, Petchlorlian A. Prevalence and associated factors of drug related problems among older people: A cross sectional study at King Chulalongkorn Memorial Hospital in Bangkok. Drugs - Real World Outcomes (2021) 8:73-84. Doi:10.1007/s40801-020-00219-2.

Sharon T, Vemparala C, Kandukuri SV, Komati M, Gottapu B. Incidence of polypharmacy and drug-related problems among elderly in tertiary care hospital-A descriptive study. Asian J Pharm Clin Res. 2022;15(9):140-4. doi:10.22159/ajpcr.2022v15i9.44618.

Sefera B, Getachew M, Babu Y, Bekele F, Fanta K. Drug-related problems and its predictors among hospitalized heart failure patients at Jimma Medical Center, South West Ethiopia: prospective interventional study. BMC Cardiovasc Disord. 2022;22(1):418-29. doi: 10.1186/s12872-022-02859-4.

Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older. The GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142-8.

Al-Ragawi A, Zyryanov S, Ushkalova E, Butranova O, Pereverzev A. Prediction of ADRs and estimation of polypharmacy in older patient’s population: Retrospective study in Russian Gerontology Center. OBM Geriatrics. 2019;3(1), doi:10.21926/obm.geriatr.1901038.

Borah L, Devi D, Debnath PK, Deka D. A study of drug utilization pattern of the geriatric patients in the department of geriatric medicine in a tertiary care hospital in Assam, India. Asian J Pharm Clin Res. 2017; 10(2):122-6. doi:10.22159/ajpcr.2017.v10i2.14762.

Coregliano-Ring L, Goia-Nishide K, Rangel ÉB. Hypokalemia in diabetes mellitus setting. Medicina (Kaunas). 2022;58(3):431. doi: 10.3390/medicina58030431. PMID: 35334607; PMCID: PMC8954285.

Benowitz NL. Antihypertensive agents. In. Katzung BG (ed). Basic and clinical pharmacology. 4th ed. New York: McGraw Hill; 2018. p. 173-276.

Jackson EK, Drug affecting renal excretory function. In: Bruntol LL, (eds). Goodman and Gilman’s the pharmacological basis of therapeutics. 14th ed. New York: McGraw-Hill; 2023. p. 557-84.

Tajuddin H, Wahyudin E, Djabir YY, Nainu F, Rahman L. Insulin therapy increases the risk of hypokalemia and arrhythmia in diabetic patients with coronary heart disease: A retrospective study in Wahidin Sudirohusodo General Hospital. Galenika Journal of Pharmacy. 2022;8(2):97–108. doi: 10.22487/j24428744.2022.v8.i2.15930

Hefner G, Hahn M, Roll SC, Klimke A, Hiemke C. Application of the GerontoNet ADR risk score in a psychiatric setting. International Journal of Clinical Medicine Research. 2018;5(1):7-14.

Petrovic M, Tangiisuran B, Rajkumar C, van der Cammen T, Onder G. Predicting the risk of adverse drug reactions in older inpatients: External validation of the GerontoNet ADR risk score using the CRIME cohort. Drugs Aging. 2017;34:135-42. doi: 10.1007/s40266-016-0428-4

Stevenson JM, Williams JI, Burnham TG, et al. Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models. Clinical Interventions in Aging. 2014:9 1581-93.

Atmaja DS, Yulistiani, Suharjono, Zairina E. Detection tools for prediction and identification of adverse drug reactions in older patients: a systematic review and meta analysis. Nature. 2022;12:13189. doi: 10.1038/s41598-022-17410-w.